AI assistant
Sending…
Cardlytics, Inc. — Director's Dealing 2022
May 31, 2022
33956_dirs_2022-05-31_1a341099-a5a1-446b-b5a3-6927f457cc80.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2022-05-27
Reporting Person: BALEN JOHN V (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-27 | Common Stock | P | 2000 | $27.5599 | Acquired | 38798 | Direct |
| 2022-05-27 | Common Stock | P | 1000 | $27.3097 | Acquired | 39798 | Direct |
| 2022-05-27 | Common Stock | P | 1000 | $27.175 | Acquired | 40798 | Direct |
| 2022-05-27 | Common Stock | P | 1000 | $27.3911 | Acquired | 41798 | Direct |
More from Cardlytics, Inc.
Delisting Announcement
2026
Jun 3
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Annual Report
2026
Mar 4
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 19